Statin use, albuminuria, and mortality risk: Re-evaluating C-reactive protein to albumin ratio in hypertensive patients based on NHANES data

Nutr Metab Cardiovasc Dis. 2024 Aug;34(8):2016-2017. doi: 10.1016/j.numecd.2024.03.032. Epub 2024 Apr 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Albuminuria* / blood
  • Albuminuria* / diagnosis
  • Albuminuria* / mortality
  • Biomarkers* / blood
  • C-Reactive Protein* / analysis
  • C-Reactive Protein* / metabolism
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Hypertension* / blood
  • Hypertension* / diagnosis
  • Hypertension* / drug therapy
  • Hypertension* / mortality
  • Male
  • Middle Aged
  • Nutrition Surveys*
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Serum Albumin, Human / analysis
  • United States / epidemiology

Substances

  • C-Reactive Protein
  • Biomarkers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Serum Albumin, Human
  • ALB protein, human